Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:1124-1125
Published online before print April 17, 2003, doi: 10.1161/01.STR.0000071141.69453.F7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/1124    most recent
01.STR.0000071141.69453.F7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballotta, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballotta, E.

(Stroke. 2003;34:1124.)
© 2003 American Heart Association, Inc.


Original Contributions

Editorial Comment—Female Sex: A Questionable Risk Factor for Carotid Endarterectomy

Enzo Ballotta, MD, Guest Editor

Section of Vascular Surgery, Department of Medical and Surgical Sciences, University of Padua School of Medicine, Padua, Italy


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The misconception that clinical manifestations of cardiovascular disease are a much more significant problem among male patients is hard to eliminate, supported by the higher incidence of cardiac, cerebrovascular, and peripheral arterial diseases in men than in women.1

Our understanding of cerebrovascular disease in women is hampered by a paucity of studies including an adequate number of female patients. Most studies are heavily biased toward the male sex. The efficacy of aspirin in primary and secondary stroke prevention trials has been demonstrated almost exclusively in men.2 Men were also the majority of the population recruited in the major clinical trials on symptomatic (North American Symptomatic Carotid Endarterectomy Trial [NASCET] and European Carotid Surgery Trial [ECST])3,4 and asymptomatic (Asymptomatic Carotid Atherosclerosis Study [ACAS]) carotid stenoses,5 and no women were enrolled in the Veteran Administration trials.6,7 Unfortunately, neither the original report from the NASCET nor the one from ECST analyzed data specifically by sex. Although the superiority of carotid endarterectomy (CEA) over the best medical management in protecting against stroke for selected symptomatic and asymptomatic patients with carotid lesions was well demonstrated,3–7 post-hoc analyses,8,9 along with several reviews and large single-center studies, have prompted a reevaluation of the role of CEA in women.10–14

The NASCET results did not distinguish, however, between men and women with regard to perioperative risk in patients with severe stenosis,3 and they showed no apparent benefit from CEA in women with moderate stenosis.8 Furthermore ACAS investigators found a slightly higher, albeit statistically insignificant, perioperative stroke and/or death rate . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
E. A. Halm, S. Tuhrim, J. J. Wang, M. Rojas, C. Rockman, T. S. Riles, and M. R. Chassin
Racial and Ethnic Disparities in Outcomes and Appropriateness of Carotid Endarterectomy: Impact of Patient and Provider Factors
Stroke, July 1, 2009; 40(7): 2493 - 2501.
[Abstract] [Full Text] [PDF]